Kenvue's Q4 Sales Miss, Margins Improve

Consumer healthcare products specialist Kenvue (NYSE:KVUE) reported mixed fourth-quarter and full-year earnings on Thursday, Feb. 6. Adjusted earnings per share (EPS) of $0.26 aligned with the market's consensus expectations. Revenue came in at $3.66 billion, falling short of the $3.76 billion estimate and effectively flat when compared to Q4 2023. Despite some headwinds, the company managed to improve its gross profit and operating income margins year over year, indicating operational efficiency gains.Source: Kenvue. Note: Analyst consensus estimates for the quarter provided by FactSet. YOY = Year over year. pps = Percentage points.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool